|
A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy |
ropinirole |
101468/168 |
|
Parkinson Disease |
Phase 3 |
|
|
|
|
Extension study 101468/248 was conducted. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. |
June 2014 |